Somerset, NJ, United States of America

Soumitesh Chakravorty

USPTO Granted Patents = 6 


Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Somerset, NJ (US) (2017 - 2023)
  • Sunnyvale, CA (US) (2024)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Soumitesh Chakravorty: Innovator in Molecular Diagnostics

Introduction

Soumitesh Chakravorty is a notable inventor based in Somerset, NJ (US). He has made significant contributions to the field of molecular diagnostics, holding a total of 6 patents. His work primarily focuses on the detection of drug resistance in microorganisms and the development of innovative diagnostic tools.

Latest Patents

Chakravorty's latest patents include advancements in polymerase chain reaction primers and probes. These inventions relate to novel primers and sloppy molecular beacons for amplifying segments from different genes to identify the presence of DNA and/or resistance to anti-tuberculosis drugs. Another significant patent involves devices, systems, and methods for strain-specific identification and assessment of susceptibility of microorganisms. This method utilizes a colorimetric sensor array to assess the resistance of microorganisms based on their metabolic products.

Career Highlights

Throughout his career, Soumitesh Chakravorty has worked with reputable institutions such as Rutgers, the State University of New Jersey, and Specific Diagnostics, LLC. His innovative work has positioned him as a key figure in the field of molecular diagnostics.

Collaborations

Chakravorty has collaborated with esteemed colleagues, including David Alland and Paul A Rhodes. These partnerships have further enhanced his research and contributions to the field.

Conclusion

Soumitesh Chakravorty is a distinguished inventor whose work in molecular diagnostics has led to significant advancements in the detection of drug resistance in microorganisms. His innovative patents and collaborations reflect his commitment to improving healthcare through technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…